Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of CS060304 in healthy subjects and individuals with elevated LDL-C; the trial is active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• CS060304

Snippet

Sponsor: Cascade Pharmaceuticals, Inc | Conditions: MASH | Phase 1 | Status: ACTIVE_NOT_RECRUITING